Latest Breaking News On - Senior scientist team leader immuno - Page 1 : comparemela.com

Cellectis to Present Pre-Clinical Data on TALEN-edited Smart CAR T-cells Supporting Improved Solid Tumor Targeting at the Society for Immunotherapy of Cancers (SITC) 37th Annual Meeting

Back to all press releases New York, NY – October 5, 2022 - Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, announced today that pre-clinical data on TALEN®-edited smart CAR T-cel

New yorkUnited statesCellectis the company euronext growthSociety for immunotherapy of cancerSenior scientist team leader immunoEuronext growthAnnual meetingSenior scientistTeam leader immuno oncologyCancer treatmentsIndustrial goods amp servicesMedical specialtiesCancer immunotherapyClinical medicineTumor antigen

Stock Market | FinancialContent Business Page

Stock Market | FinancialContent Business Page
financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesFrance generalNorth carolinaAshleyr robinsonMargaret gandolfoArthur strilPascalyne wilsonCellectis the company euronext growthSecurities exchange commissionSociety for immunotherapy of cancerSenior scientist team leader immunoEuronext growthAnnual meetingSenior scientistTeam leader immuno oncology